{
  "resourceType": "Bundle",
  "id": "GOFSH-GENERATED-ID-248",
  "type": "collection",
  "entry": [
    {
      "resource": {
        "resourceType": "MedicinalProductDefinition",
        "id": "Zinacef-250mg-Powder-SE-IS-MedicinalProductDefinition",
        "meta": {
          "profile": [
            "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
          ]
        },
        "identifier": [
          {
            "system": "http://ema.europa.eu/fhir/mpId",
            "value": "SE-100000848-00050970"
          },
          {
            "system": "http://ema.europa.eu/fhir/eurdId",
            "value": "615"
          }
        ],
        "combinedPharmaceuticalDoseForm": {
          "coding": [
            {
              "code": "100000116186",
              "system": "https://spor.ema.europa.eu/v1/lists/200000000004",
              "display": "Powder for solution for injection/infusion"
            }
          ]
        },
        "domain": {
          "coding": [
            {
              "code": "100000000012",
              "system": "https://spor.ema.europa.eu/v1/lists/100000000004",
              "display": "Human use"
            }
          ]
        },
        "status": {
          "coding": [
            {
              "code": "200000005004",
              "system": "https://spor.ema.europa.eu/v1/lists/200000005003",
              "display": "Current"
            }
          ]
        },
        "indication": "Zinacef är avsett för behandling av nedanstående infektioner hos vuxna och barn, även nyfödda (från  födelsen). • Samhällsförvärvad pneumoni. • Akut exacerbation av kronisk bronkit. • Komplicerade urinvägsinfektioner, även pyelonefrit. • Mjukdelsinfektioner: cellulit, erysipelas och sårinfektioner. • Intraabdominella infektioner. • Profylax mot infektion inför gastrointestinal (även esofageal), ortopedisk, kardiovaskulär och  gynekologisk operation (även kejsarsnitt).  Vid behandling och förebyggande av infektioner då det är mycket troligt att anaeroba organismer påträffas  ska cefuroxim administreras tillsammans med ett lämpligt antianaerobt antibiotikum.  Hänsyn ska tas till officiella riktlinjer om lämplig användning av antibakteriella medel.",
        "legalStatusOfSupply": {
          "coding": [
            {
              "code": "100000072084",
              "system": "https://spor.ema.europa.eu/v1/lists/100000072051",
              "display": "Medicinal product subject to medical prescription"
            }
          ]
        },
        "classification": [
          {
            "coding": [
              {
                "code": "100000093533",
                "system": "https://spor.ema.europa.eu/v1/lists/100000116677",
                "display": "J01DC02"
              }
            ]
          }
        ],
        "name": [
          {
            "productName": "Zinacef 250 mg Pulver till injektions-/infusionsvätska, lösning"
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "RegulatedAuthorization",
        "id": "Zinacef-250mg-Powder-SE-IS-RegulatedAuthorization",
        "meta": {
          "profile": [
            "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
          ]
        },
        "type": {
          "coding": [
            {
              "system": "https://spor.ema.europa.eu/v1/lists/220000000060",
              "code": "220000000061",
              "display": "Marketing Authorisation"
            }
          ]
        },
        "identifier": [
          {
            "system": "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
            "value": "50970"
          }
        ],
        "subject": [
          {
            "reference": "MedicinalProductDefinition/Zinacef-250mg-Powder-SE-IS-MedicinalProductDefinition"
          }
        ],
        "region": [
          {
            "coding": [
              {
                "code": "100000000535",
                "system": "https://spor.ema.europa.eu/v1/lists/100000000002",
                "display": "Sweden"
              }
            ]
          }
        ],
        "status": {
          "coding": [
            {
              "code": "100000072099",
              "system": "https://spor.ema.europa.eu/v1/lists/100000072049",
              "display": "Valid"
            }
          ]
        },
        "statusDate": "2015-03-19",
        "case": {
          "type": {
            "coding": [
              {
                "code": "dateOfFirstAuthorisation",
                "system": "https://ema.europa.eu/fhir/authorisationDateType",
                "display": "First Authorisation"
              }
            ]
          },
          "dateDateTime": "2015-03-19"
        },
        "holder": {
          "reference": "Organization/LOC-100001468"
        }
      }
    },
    {
      "resource": {
        "resourceType": "AdministrableProductDefinition",
        "id": "Zinacef-250mg-Powder-SE-IS-AdministrableProductDefinition",
        "meta": {
          "profile": [
            "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
          ]
        },
        "status": "active",
        "formOf": [
          {
            "reference": "MedicinalProductDefinition/Zinacef-250mg-Powder-SE-IS-MedicinalProductDefinition"
          }
        ],
        "administrableDoseForm": {
          "coding": [
            {
              "code": "100000074038",
              "system": "https://spor.ema.europa.eu/v1/lists/200000000004",
              "display": "Solution for injection/infusion"
            }
          ]
        },
        "producedFrom": [
          {
            "reference": "ManufacturedItemDefinition/Zinacef-250mg-Powder-SE-IS-ManufacturedItemDefinition"
          }
        ],
        "routeOfAdministration": [
          {
            "code": {
              "coding": [
                {
                  "code": "100000073600",
                  "system": "https://spor.ema.europa.eu/v1/lists/100000073345",
                  "display": "Intramuscular use"
                },
                {
                  "code": "100000073611",
                  "system": "https://spor.ema.europa.eu/v1/lists/100000073345",
                  "display": "Intravenous use"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "PackagedProductDefinition",
        "id": "Zinacef-250mg-Powder-SE-IS-PackagedProductDefinition",
        "meta": {
          "profile": [
            "http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"
          ]
        },
        "identifier": [
          {
            "system": "http://ema.europa.eu/example/pcid"
          }
        ],
        "packaging": {
          "type": {
            "coding": [
              {
                "system": "https://spor.ema.europa.eu/v1/lists/100000073346",
                "code": "100000073498",
                "display": "Box"
              }
            ]
          },
          "quantity": 1
        },
        "containedItemQuantity": [
          {
            "value": 1,
            "code": "200000002158",
            "system": "http://spor.ema.europa.eu/v1/lists/200000000014",
            "unit": "Vial"
          }
        ],
        "packageFor": [
          {
            "reference": "MedicinalProductDefinition/Zinacef-250mg-Powder-SE-IS-MedicinalProductDefinition"
          }
        ],
        "description": "Injektionsflaska, 5 st (5 x 250 mg)",
        "marketingStatus": [
          {
            "country": {
              "coding": [
                {
                  "code": "100000000535",
                  "system": "https://spor.ema.europa.eu/v1/lists/100000000002",
                  "display": "Sweden"
                }
              ]
            },
            "status": {
              "coding": [
                {
                  "code": "100000072083",
                  "system": "https://spor.ema.europa.eu/v1/lists/100000072052",
                  "display": "Marketed"
                }
              ]
            }
          }
        ]
      }
    },
    {
      "resource": {
        "resourceType": "ManufacturedItemDefinition",
        "id": "Zinacef-250mg-Powder-SE-IS-ManufacturedItemDefinition",
        "meta": {
          "profile": [
            "http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"
          ]
        },
        "status": "active",
        "manufacturedDoseForm": {
          "coding": [
            {
              "code": "100000116186",
              "system": "https://spor.ema.europa.eu/v1/lists/200000000004",
              "display": "Powder for solution for injection/infusion"
            }
          ]
        },
        "unitOfPresentation": {
          "coding": [
            {
              "code": "200000002158",
              "system": "https://spor.ema.europa.eu/v1/lists/200000000014",
              "display": "Vial"
            }
          ]
        }
      }
    },
    {
      "resource": {
        "resourceType": "Ingredient",
        "id": "Zinacef-250mg-Powder-SE-IS-Ingredient",
        "meta": {
          "profile": [
            "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
          ]
        },
        "status": "active",
        "for": [
          {
            "reference": "MedicinalProductDefinition/Zinacef-250mg-Powder-SE-IS-MedicinalProductDefinition"
          },
          {
            "reference": "ManufacturedItemDefinition/Zinacef-250mg-Powder-SE-IS-ManufacturedItemDefinition"
          },
          {
            "reference": "AdministrableProductDefinition/Zinacef-250mg-Powder-SE-IS-AdministrableProductDefinition"
          }
        ],
        "role": {
          "coding": [
            {
              "code": "100000072072",
              "system": "https://spor.ema.europa.eu/v1/lists/100000072050",
              "display": "Active"
            }
          ]
        },
        "substance": {
          "code": {
            "concept": {
              "coding": [
                {
                  "code": "100000091436",
                  "system": "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
                  "display": "cefuroxime sodium"
                }
              ]
            }
          },
          "strength": [
            {
              "concentrationRatio": {
                "numerator": {
                  "value": 263,
                  "code": "100000110655",
                  "system": "http://spor.ema.europa.eu/v1/lists/100000110633",
                  "unit": "milligram(s)"
                },
                "denominator": {
                  "value": 1,
                  "code": "100000110756",
                  "system": "http://spor.ema.europa.eu/v1/lists/100000110633",
                  "unit": "unit(s)"
                }
              },
              "referenceStrength": [
                {
                  "substance": {
                    "concept": {
                      "coding": [
                        {
                          "code": "100000092667",
                          "system": "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
                          "display": "cefuroxime"
                        }
                      ]
                    }
                  },
                  "strengthRatio": {
                    "numerator": {
                      "value": 250,
                      "code": "100000110655",
                      "system": "http://spor.ema.europa.eu/v1/lists/100000110633",
                      "unit": "milligram(s)"
                    },
                    "denominator": {
                      "value": 1,
                      "code": "100000110756",
                      "system": "http://spor.ema.europa.eu/v1/lists/100000110633",
                      "unit": "unit(s)"
                    }
                  }
                }
              ]
            }
          ]
        }
      }
    }
  ]
}
